Gender Neutral
Type Module
Testing Phase validated

Project summary

Please note that the QLQ-BR23 has been replaced by the QLQ-BR42. It is a more recent, updated version of this questionnaire, and it should be used instead of the QLQ-BR23.

 

Changes and advances are constantly being made in cancer research. Consequently, a module may need to be updated, to ensure that it addresses key QoL issues relevant to current treatments. This was the reason to update the QLQ-BR23.

Translations

A

Afrikaans
Amharic
Arabic

B

Belarusian
Bengali
Bosnian
Bulgarian

C

Catalan
Cebuano
Chichewa
Chinese Cantonese (Hong Kong)
Chinese Mandarin (China)
Chinese Mandarin (Malaysia)
Chinese Mandarin (Singapore)
Chinese Mandarin (Taiwan)
Croatian
Czech

D

Danish
Dutch

E

English
Estonian

F

Finnish
French (Canada)
French (Europe)

G

Georgian
German
Greek
Gujarati

H

Hebrew
Hiligaynon
Hindi
Hungarian

I

Ilocano
Indonesian
Italian

J

Japanese

K

Kannada
Kazakh
Korean

L

Latvian
Lithuanian
Luganda

M

Macedonian
Malay (Malaysia)
Malay (Singapore)
Malayalam
Maltese
Marathi
Montenegrin

N

Norwegian

O

Oriya

P

Persian
Polish
Portuguese (Brazil)
Portuguese (Portugal)
Punjabi

R

Romanian
Russian
Russian (Belarus)

S

Serbian
Sinhala
Slovak
Slovenian
Sotho
Spanish (Argentina)
Spanish (Chile)
Spanish (Colombia)
Spanish (Costa Rica)
Spanish (Ecuador)
Spanish (Guatemala)
Spanish (Mexico)
Spanish (Panama)
Spanish (Peru)
Spanish (Puerto Rico)
Spanish (Spain)
Spanish (US)
Spanish (Uruguay)
Swahili
Swedish

T

Tagalog
Tamil (India)
Tamil (Malaysia)
Tamil (Singapore)
Tamil (Sri Lanka)
Telugu
Thai
Tswana
Turkish

U

Ukrainian
Urdu (India)

V

Vietnamese

W

Welsh

X

Xhosa

Y

Yoruba

Z

Zulu
Go to Top